Trade Summary

6 days ago, Winningham Rick E, serving as Dir at Jazz Pharmaceuticals plc (JAZZ), sold 2,741 shares at $241.57 per share, for a total transaction value of $662,143.37. Following this transaction, Winningham Rick E now holds 9,567 shares of JAZZ.

This sale represents a 22.27% decrease in Winningham Rick E's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, May 22, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, May 27, 2026 at 6:13 PM ET, 5 days after the trade was made.

Jazz Pharmaceuticals plc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.